ProMIS Neurosciences, Inc.
PMN
$0.50
$0.0122.46%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 95.40% | 8.05% | -46.70% | -67.70% | -75.27% |
| Gross Profit | -95.40% | -8.05% | 46.70% | 67.70% | 75.27% |
| SG&A Expenses | -51.60% | -57.84% | -10.29% | -18.79% | 0.85% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.94% | -6.56% | -22.27% | -43.06% | -46.21% |
| Operating Income | -31.94% | 6.56% | 22.27% | 43.06% | 46.21% |
| Income Before Tax | 92.14% | 121.03% | 96.67% | 40.47% | 43.19% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 92.14% | 121.03% | 96.67% | 40.47% | 43.19% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 92.14% | 121.03% | 96.67% | 40.47% | 43.19% |
| EBIT | -31.94% | 6.56% | 22.27% | 43.06% | 46.21% |
| EBITDA | 25.56% | 6.57% | 22.43% | 43.17% | 46.30% |
| EPS Basic | 95.02% | 98.64% | 89.87% | 72.72% | 68.71% |
| Normalized Basic EPS | 107.12% | 106.86% | 89.87% | 72.71% | 70.28% |
| EPS Diluted | 95.02% | 98.64% | 89.87% | 72.72% | 68.71% |
| Normalized Diluted EPS | 107.06% | 106.83% | 89.84% | 72.71% | 70.28% |
| Average Basic Shares Outstanding | 98.88% | 112.05% | 134.27% | 117.41% | 91.34% |
| Average Diluted Shares Outstanding | 98.95% | 112.14% | 134.39% | 117.41% | 91.34% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |